Olema Pharmaceuticals, Inc. OLMA 深 滬
已收盤 02-06 16:00:00 美东时间
25.36
+0.350
+1.40%
華盛通- 最 高26.48
- 今 開25.57
- 成交量 96.23万股
- 最 低 25.235
- 昨 收 25.01
- 總市值 19.95亿
- 52周最高 36.2591
- 市盈率 靜 --
- 換手率 1.22%
- 52周最低 2.86
- 委 比 51.57%
- 總股本 7865.99万
- 歷史最高 60.27
- 量 比 0.52
- 振 幅 4.98%
- 歷史最低 2.00
- 每 手 1
- 風險率 8.99%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Olema Pharmaceuticals Grants Stock Options to New Employees Under Inducement Plan
Olema Pharmaceuticals Grants Stock Options to New Employees Under Inducement Plan Olema Pharmaceuticals Inc. has granted stock options to two new employees, allowing them to purchase a total of 24,000 shares of the company's common stock. The options vest over four years, with 25 percent vesting aft
02-04 05:30
BRIEF-Olema Oncology Announces Departure Of Chief Operating And Financial Officer
BRIEF-Olema Oncology Announces Departure Of Chief Operating And Financial Officer Olema Pharmaceuticals Inc OLMA.O : OLEMA ONCOLOGY ANNOUNCES DEPARTURE OF CHIEF OPERATING AND FINANCIAL OFFICER OLEMA PHARMACEUTICALS INC - ONCOLOGY ANNOUNCES DEPARTURE OF COO AND CFO SHANE KOVACS OLEMA PHARMACEUTICALS
01-31 05:05
Olema Pharmaceuticals COO, CFO Shane Kovacs Departing, Effective Immediately
Olema Pharmaceuticals, Inc. (("Olema", or "Olema Oncology", NASDAQ:OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for breast
01-31 05:02
Director Cyrus Harmon Reports Disposal of Olema Pharmaceuticals Inc. Common Shares
Director Cyrus Harmon Reports Disposal of Olema Pharmaceuticals Inc. Common Shares Cyrus Harmon, Director at Olema Pharmaceuticals Inc., has reported the disposal of common shares of the company. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Publi
01-22 10:00
Glaukos, Trip.com Group And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
U.S. stock futures were lower this morning, with the Dow futures falling around...
01-14 21:05
美股大行评级 | 瑞银上调美光科技目标价从300美元升至400美元；Freedom上调百度目标价从120美元升至160美元
今日重点评级关注：Needham：维持Vaxcyte"买入"评级，目标价从90美元升至110美元；Citizens: 维持LGI Homes"跑赢大市"评级，目标价从85美元升至95美元
01-08 18:33
UBS Initiates Coverage On Olema Pharmaceuticals with Buy Rating, Announces Price Target of $45
UBS analyst Michael Yee initiates coverage on Olema Pharmaceuticals (NASDAQ:OLMA) with a Buy rating and announces Price Target of $45.
01-08 04:25
Olema Oncology to Present at 44th Annual J.P. Morgan Healthcare Conference
Olema Pharmaceuticals, Inc. announced that its CEO, Sean P. Bohen, M.D., Ph.D., will present at the 44th Annual J.P. Morgan Healthcare Conference on January 13, 2025. The presentation will be available via live webcast and recording on Olema’s Investor Relations website. Olema focuses on developing targeted therapies for breast cancer, with its lead candidate, palazestrant, in Phase 3 trials, and OP-3136 in Phase 1 testing. The company is headqua...
01-05 12:00
美股周涨跌榜 | 特朗普媒体科技集团周涨51.1%，拟并购TAE转型聚变能源公司；Medline周涨43.6%
DJT周涨51.1%，拟并购TAE转型聚变能源公司；Medline周涨43.6%，本周首挂上市，为年内全球最大规模IPO；爱美医疗周涨34.4%，获拜玛林制药48亿美元收购>>
2025-12-20 09:40
美股牛股 | KYTX大涨超23%，Miv-cel临床试验取得积极成果；以星航运涨近9%，获瑞士航运集团收购要约
KYTX大涨超23%，Miv-cel临床试验取得积极成果；IMNM涨近16%，实验性药物晚期临床试验达主要终点；以星航运涨近9%，获瑞士航运集团收购要约>>
2025-12-16 19:53
